This functionality is implemented using Javascript. It cannot work without it, etc...

We are loading the information...

Skip to main content

Medical Policies

Medical policies are documents that define the plan coverage for technologies, procedures and treatments. The statements of medical necessity in the policies, about whether a technology, procedure, treatment, supply, equipment, drug or other service improves the health outcome of the population for which said technology or treatment was designed are based on scientific evidence, clinical studies and professional opinions from our providers and recognized medical organizations.

Each document displayed on this website is provided for informational purposes only and is not an authorization, explanation of benefits, or contract. Receiving benefits is subject to satisfaction of all terms and conditions of coverage. Medical technology is constantly changing, and we reserve the right to periodically review and update our policies.

ID Title Last Review Next Review Description Access
11.003.064 Genetic Cancer Susceptibility Panels Using Next Generation Sequencing Dec 12, 2024 Nov 20, 2025 Commercially available cancer susceptibility gene panels can test for multiple variants associated with a... View
11.003.066 Genetic Testing For Duchenne And Becker Muscular Dystrophy Apr 10, 2025 Apr 20, 2026 Variants in the duchenne muscular dystrophy (dmd) gene, which encodes the protein dystrophin, may result in a... View
11.003.067 Genotype-Guided Warfarin Dosing Jul 08, 2024 Jul 20, 2025 Using information about an individual's genotype may help in guiding warfarin dosing and could reduce... View
11.003.068 Genetic Testing For The Diagnosis Of Inherited Peripheral Neuropathies Feb 20, 2025 Feb 20, 2026 Description the inherited peripheral neuropathies are a heterogeneous group of diseases that may be inherited... View
11.003.069 Analysis Of Mgmt Promoter Methylation In Malignant Gliomas Jun 13, 2019 Policy Archived Testing for o6-methylguanine-dna methyltransferase (mgmt) gene promoter methylation has been proposed as a... View
11.003.070 Preimplantation Genetic Testing Dec 06, 2024 Sep 20, 2025 Preimplantation genetic testing involves the analysis of biopsied cells as part of an assisted reproductive... View
11.003.072 Genetic Testing For Marfan Syndrome, Thoracic Aortic Aneurysms And Dissections, And Related Disorders Mar 20, 2025 Mar 20, 2026 Marfan syndrome (mfs) is a systemic connective tissue disease (ctd) with a high degree of clinical... View
11.003.073 Laboratory And Genetic Testing For Use Of 5-Fluorouracil In Patients With Cancer Apr 18, 2025 Apr 20, 2026 Variability in systemic exposure to 5-fluorouracil chemotherapy is thought to directly impact 5-fluorouracil... View
11.003.075 Proteomic Testing For Targeted Therapy In Non-Small-Cell Lung Cancer Dec 06, 2024 Dec 20, 2025 Proteomic testing has been proposed as a way to predict survival outcomes, as well as the response to and... View
11.003.076 Multibiomarker Disease Activity Blood Test For Rheumatoid Arthritis Jul 19, 2024 Jul 20, 2025 Assessment of disease activity in rheumatoid arthritis (ra) is an important component of management with a... View
11.003.077 Los ensayos de varios analitos con el análisis algorítmico para predecir el ries Oct 11, 2016 Policy Archived ... View
11.003.078 Noninvasive Prenatal Screening For Fetal Aneuploidies And Microdeletions Using Cell-Free Fetal Dna Apr 22, 2025 Apr 20, 2026 National guidelines recommend that all pregnant individuals be offered screening for fetal chromosomal... View
11.003.079 Invasive Prenatal (Fetal) Diagnostic Testing Sep 13, 2024 Sep 20, 2025 Invasive prenatal (fetal) diagnostic testing may be used to identify pathogenic genetic alterations in... View
11.003.081 Genetic Testing For Macular Degeneration Apr 22, 2025 Apr 20, 2026 Age-related macular degeneration is a complex disease involving both genetic and environmental influences.... View
11.003.082 Genetic Testing For Facioscapulohumeral Muscular Dystrophy Mar 12, 2025 Mar 20, 2026 Facioscapulohumeral muscular dystrophy (fshd) is an autosomal dominant disease that typically presents before... View
11.003.083 Genetic Testing For Charge Syndrome Mar 12, 2025 Mar 20, 2026 Charge syndrome is a rare genetic condition associated with multiple congenital anomalies. in many... View
11.003.084 Genetic Testing For Idiopathic Dilated Cardiomyopathy Mar 12, 2025 Mar 20, 2026 Dilated cardiomyopathy (dcm) is characterized by progressive left ventricular enlargement and systolic... View
11.003.085 Genetic Testing For Limb-Girdle Muscular Dystrophies Jun 18, 2024 Policy Archived ... View
11.003.086 Kif6 Genotyping For Predicting Cardiovascular Risk Aug 20, 2021 Policy Archived Genetic testing to determine kinesin-like protein 6 (kif6) trp719arg variant status is being evaluated as a... View
11.003.087 Molecular Testing In The Management Of Pulmonary Nodules Jun 18, 2024 Jun 20, 2025 Plasma-based proteomic screening and gene expression profiling of bronchial brushing are molecular tests... View

Want to be up to date on topics like health, trending news, useful tips, lifestyles and more?

Subscribe to our blog and don't miss out on anything!

Subscribe to the blog

We want to personalize the content according to your preferences

Please select one or more categories to continue

Thanks for subscribing!

You will receive information of interest in your email.

787-277-6653 787-474-6326